# Switching Patients with Non-Dialysis Chronic Kidney Disease from Oral Iron to Intravenous Ferric Carboxymaltose: Effects on Erythropoiesis-Stimulating Agent Requirements, Costs, Hemoglobin and Iron Status

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/switching-patients-with-non-dialysis-chronic-kidney-disease-from-oral-iron-to/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jorge E. Toblli,Federico Di Gennaro |
| Citations | 18 |
| DOI | 10.1371/journal.pone.0125528 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0125528&type=printable |
| OpenAlex ID | https://openalex.org/W2028621618 |
| PMID | 25928811 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Federico Di Gennaro](https://scholariq.org/researchers/federico-di-gennaro/)

## Paper journal

- [PLoS ONE](https://scholariq.org/journals/plos-one/)

## Paper primary topic

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)

## Paper topics

- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Iron Metabolism and Disorders](https://scholariq.org/topics/iron-metabolism-and-disorders/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.